Expression	O
of	O
IkappaBalpha	B-protein
in	O
the	O
nucleus	O
of	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

According	O
to	O
current	O
models	O
the	O
inhibitory	O
capacity	O
of	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
would	O
be	O
mediated	O
through	O
the	O
retention	O
of	O
Rel/NF-kappaB	B-protein
proteins	I-protein
in	O
the	O
cytosol	B-cell_type
.	O

However	O
,	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
has	O
also	O
been	O
detected	O
in	O
the	O
nucleus	O
of	O
cell	O
lines	O
and	O
when	O
overexpressed	O
by	O
transient	O
transfection	O
.	O

To	O
gain	O
better	O
insight	O
into	O
the	O
potential	O
role	O
of	O
nuclear	B-protein
I	I-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
in	O
a	O
physiological	O
context	O
we	O
have	O
analysed	O
its	O
presence	O
in	O
the	O
nucleus	O
of	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
(	O
PBL	B-cell_type
)	O
.	O

We	O
demonstrate	O
the	O
nuclear	O
localization	O
of	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
in	O
PBL	B-cell_type
by	O
different	O
techniques	O
:	O
Western	O
blot	O
,	O
indirect	O
immunofluorescence	O
and	O
electron	O
microscopy	O
.	O

Low	O
levels	O
of	O
nuclear	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
were	O
detected	O
in	O
resting	O
cells	O
whereas	O
a	O
superinduction	O
was	O
obtained	O
after	O
PMA	O
activation	O
.	O

The	O
nuclear	O
pool	O
of	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
showed	O
a	O
higher	O
stability	O
than	O
cytosolic	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
and	O
was	O
partially	O
independent	O
of	O
the	O
resynthesis	O
of	O
the	O
protein	O
.	O

Unexpectedly	O
,	O
the	O
presence	O
of	O
nuclear	B-protein
I	I-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
did	O
not	O
inhibit	O
NF-kappaB	B-protein
binding	O
to	O
DNA	O
and	O
this	O
phenomenon	O
was	O
not	O
due	O
to	O
the	O
presence	O
of	O
IkappaBbeta	B-protein
at	O
the	O
nuclear	O
level	O
.	O

Immunoprecipitation	O
experiments	O
failed	O
to	O
demonstrate	O
an	O
association	O
between	O
nuclear	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
and	O
NF-kappaB	B-protein
proteins	O
.	O

Our	O
results	O
demonstrate	O
that	O
in	O
resting	O
and	O
PMA-activated	B-cell_type
human	I-cell_type
PBL	I-cell_type
,	O
I	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
(	I-protein
alpha	I-protein
)	I-protein
is	O
present	O
in	O
the	O
nucleus	O
in	O
an	O
apparently	O
inactive	O
form	O
unable	O
to	O
disrupt	O
NF-kappaB	B-protein
binding	O
from	O
DNA	O
.	O

Oncogene	NULL
(	NULL
1999	NULL
)	NULL
18	NULL
,	NULL
1581-1588	NULL
©	NULL
1999	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/99	NULL
$	NULL
12.00	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

stockton-press.co.uk/onc	NULL
Expression	NULL
of	NULL
IxBa	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
Teresa	NULL
Lain	NULL
de	NULL
Lera'*	NULL
,	NULL
Lola	NULL
Folgueira	NULL
'	NULL
,	NULL
Angel	NULL
G	NULL
Martin®	NULL
,	NULL
Catherine	NULL
Dargemont	NULL
,	NULL
Maria-Antonia	NULL
Pedraza	NULL
'	NULL
,	NULL
Mercedes	NULL
Bermejo	NULL
'	NULL
,	NULL
Pedro	NULL
Bonay	NULL
'	NULL
,	NULL
Manuel	NULL
Fresno*	NULL
and	NULL
José	NULL
Alcami	NULL
'	NULL
'Servicio	NULL
de	NULL
Microbiologia	NULL
,	NULL
Centro	NULL
de	NULL
Investigacion	NULL
,	NULL
Hospital	NULL
12	NULL
de	NULL
Octubre	NULL
,	NULL
Madrid	NULL
,	NULL
Spain	NULL
;	NULL
``	NULL
Laboratoire	NULL
de	NULL
Transport	NULL
Nucleocytoplasmique	NULL
,	NULL
UMR	NULL
144	NULL
.	NULL

Institut	NULL
Curie	NULL
,	NULL
CNRS	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
'Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
Universidad	NULL
Autonoma	NULL
,	NULL
Madrid	NULL
,	NULL
Spain	NULL
According	NULL
to	NULL
current	NULL
models	NULL
the	NULL
inhibitory	NULL
capacity	NULL
of	NULL
IxB	NULL
«	NULL
would	NULL
be	NULL
mediated	NULL
through	NULL
the	NULL
retention	NULL
of	NULL
Rel/	NULL
NF-xB	NULL
proteins	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

However	NULL
,	NULL
IxBa	NULL
has	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
cell	NULL
lines	NULL
and	NULL
when	NULL
overexpressed	NULL
by	NULL
transient	NULL
transfection	NULL
.	NULL

To	NULL
gain	NULL
better	NULL
insight	NULL
into	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
nuclear	NULL
IxB	NULL
«	NULL
in	NULL
a	NULL
physiological	NULL
context	NULL
we	NULL
have	NULL
analysed	NULL
its	NULL
presence	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
PBL	NULL
by	NULL
different	NULL
techniques	NULL
:	NULL
Western	NULL
blot	NULL
,	NULL
indirect	NULL
immunofluorescence	NULL
and	NULL
electron	NULL
microscopy	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
nuclear	NULL
IxBa	NULL
«	NULL
were	NULL
detected	NULL
in	NULL
resting	NULL
cells	NULL
whereas	NULL
a	NULL
superinduction	NULL
was	NULL
obtained	NULL
after	NULL
PMA	NULL
activation	NULL
.	NULL

The	NULL
nuclear	NULL
pool	NULL
of	NULL
IxB	NULL
«	NULL
showed	NULL
a	NULL
higher	NULL
stability	NULL
than	NULL
cytosolic	NULL
IxBx	NULL
and	NULL
was	NULL
partially	NULL
independent	NULL
of	NULL
the	NULL
resynthesis	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Unexpectedly	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
IxBa	NULL
&	NULL
did	NULL
not	NULL
inhibit	NULL
NF-xB	NULL
binding	NULL
to	NULL
DNA	NULL
and	NULL
this	NULL
phenomenon	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
the	NULL
nuclear	NULL
level	NULL
.	NULL

Immunoprecipitation	NULL
experiments	NULL
failed	NULL
to	NULL
demonstrate	NULL
an	NULL
association	NULL
between	NULL
nuclear	NULL
and	NULL
NF-xB	NULL
proteins	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
in	NULL
resting	NULL
and	NULL
PMA-activated	NULL
human	NULL
PBL	NULL
,	NULL
is	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
in	NULL
an	NULL
apparently	NULL
inactive	NULL
form	NULL
unable	NULL
to	NULL
disrupt	NULL
NF-xB	NULL
binding	NULL
from	NULL
DNA	NULL
.	NULL

Keywords	NULL
:	NULL
IK	NULL
Ba	NULL
;	NULL
NF-xB	NULL
;	NULL
nuclear	NULL
;	NULL
T	NULL
lymphocytes	NULL
Introduction	NULL
The	NULL
Rel/NF-xB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
,	NULL
cell	NULL
differentiation	NULL
and	NULL
control	NULL
of	NULL
apoptosis	NULL
(	NULL
reviewed	NULL
by	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1996	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
NF-xB	NULL
is	NULL
an	NULL
important	NULL
regulatory	NULL
element	NULL
for	NULL
HIV	NULL
replication	NULL
in	NULL
normal	NULL
CD4	NULL
T	NULL
lymphocytes	NULL
(	NULL
Alcami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
human	NULL
Rel/NF-xB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
include	NULL
NF-xB1	NULL
(	NULL
p50	NULL
)	NULL
(	NULL
Bours	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
NF-xB2	NULL
(	NULL
p52	NULL
)	NULL
(	NULL
Neri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
RelB	NULL
(	NULL
Dobrzanski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
Nakayama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
the	NULL
proteins	NULL
p105	NULL
and	NULL
p100	NULL
(	NULL
Bours	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Neri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
classically	NULL
considered	NULL
as	NULL
precursor	NULL
proteins	NULL
of	NULL
Correspondence	NULL
:	NULL
J	NULL
Alcami	NULL
*Current	NULL
address	NULL
:	NULL
Centro	NULL
Nacional	NULL
de	NULL
Biotecnologia	NULL
,	NULL
Universidad	NULL
Autonoma	NULL
,	NULL
Madrid	NULL
,	NULL
Spain	NULL
Received	NULL
12	NULL
February	NULL
1998	NULL
;	NULL
revised	NULL
21	NULL
September	NULL
1998	NULL
;	NULL
accepted	NULL
21	NULL
September	NULL
1998	NULL
p50	NULL
and	NULL
p52	NULL
respectively	NULL
,	NULL
although	NULL
recently	NULL
it	NULL
has	NULL
been	NULL
pointed	NULL
out	NULL
(	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
that	NULL
p105	NULL
and	NULL
p50	NULL
do	NULL
not	NULL
exhibit	NULL
a	NULL
precursor-product	NULL
relationship	NULL
.	NULL

All	NULL
these	NULL
proteins	NULL
share	NULL
a	NULL
conserved	NULL
region	NULL
,	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
(	NULL
RHD	NULL
)	NULL
which	NULL
contains	NULL
sequences	NULL
involved	NULL
in	NULL
DNA	NULL
binding	NULL
,	NULL
protein	NULL
dimerization	NULL
,	NULL
nuclear	NULL
localization	NULL
sequences	NULL
and	NULL
domains	NULL
of	NULL
interaction	NULL
with	NULL
their	NULL
inhibitors	NULL
(	NULL
reviewed	NULL
by	NULL
Baeuerle	NULL
and	NULL
Henkel	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
different	NULL
Rel/NF-xB	NULL
subunits	NULL
associate	NULL
through	NULL
the	NULL
RHD	NULL
forming	NULL
homo-	NULL
or	NULL
heterodimers	NULL
with	NULL
different	NULL
affinities	NULL
and	NULL
transcriptional	NULL
activities	NULL
on	NULL
the	NULL
different	NULL
xB	NULL
consensus	NULL
sequences	NULL
(	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Kretz-schmar	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
main	NULL
regulatory	NULL
mechanism	NULL
of	NULL
NF-xB	NULL
is	NULL
mediated	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
inhibitory	NULL
proteins	NULL
-	NULL
IxB	NULL
molecules	NULL
-	NULL
that	NULL
retain	NULL
NF-xB	NULL
in	NULL
the	NULL
cytosolic	NULL
compartment	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Verma	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
IxB	NULL
family	NULL
includes	NULL
IxBa	NULL
«	NULL
(	NULL
Haskill	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
IxBB	NULL
(	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
p105	NULL
and	NULL
p100	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
IxBse	NULL
(	NULL
Whiteside	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
and	NULL
Bcl3	NULL
(	NULL
Ohno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

All	NULL
these	NULL
proteins	NULL
are	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
ankyrin	NULL
repeats	NULL
in	NULL
their	NULL
structure	NULL
and	NULL
their	NULL
capacity	NULL
to	NULL
bind	NULL
Rel/NF-xB	NULL
transcription	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
Baeuerle	NULL
and	NULL
Henkel	NULL
,	NULL
1994	NULL
;	NULL
Beg	NULL
and	NULL
Baldwin	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Following	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
different	NULL
stimuli	NULL
such	NULL
as	NULL
antigen	NULL
recognition	NULL
,	NULL
cytokines	NULL
,	NULL
tumor	NULL
promoters	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
lipopolysacaride	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
infection	NULL
with	NULL
different	NULL
viruses	NULL
,	NULL
NF-kB	NULL
dissociates	NULL
from	NULL
IxB	NULL
«	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Baeuerle	NULL
and	NULL
Henkel	NULL
,	NULL
1994	NULL
;	NULL
Baldwin	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Upon	NULL
cell	NULL
activation	NULL
IxBa	NULL
is	NULL
targeted	NULL
to	NULL
degradation	NULL
by	NULL
signal-induced	NULL
phosphorylation	NULL
(	NULL
Beg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Finco	NULL
and	NULL
Baldwin	NULL
,	NULL
1995	NULL
)	NULL
and	NULL
the	NULL
protein	NULL
is	NULL
subsequently	NULL
conjugated	NULL
to	NULL
ubiquitine	NULL
and	NULL
degraded	NULL
in	NULL
the	NULL
proteasome	NULL
(	NULL
Traenckner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Roff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

However	NULL
,	NULL
besides	NULL
its	NULL
cytosolic	NULL
localization	NULL
,	NULL
IxBa	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
when	NULL
it	NULL
is	NULL
overexpressed	NULL
by	NULL
transient	NULL
transfection	NULL
(	NULL
Morin	NULL
and	NULL
Gilmore	NULL
,	NULL
1992	NULL
;	NULL
Cressman	NULL
and	NULL
Taub	NULL
,	NULL
1993	NULL
;	NULL
Arenzana-Seisdedos	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
a	NULL
nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
associated	NULL
to	NULL
NF-xB	NULL
complexes	NULL
has	NULL
been	NULL
demonstrated	NULL
suggesting	NULL
a	NULL
regulation	NULL
of	NULL
xB-dependent	NULL
transcription	NULL
by	NULL
IxBa	NULL
«	NULL
at	NULL
the	NULL
nuclear	NULL
level	NULL
(	NULL
Arenzana-Seisdedos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
nuclear	NULL
exporting	NULL
sequences	NULL
(	NULL
NES	NULL
)	NULL
in	NULL
the	NULL
IxBa	NULL
molecule	NULL
has	NULL
been	NULL
described	NULL
indicating	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
IxBa	NULL
«	NULL
in	NULL
the	NULL
mechanisms	NULL
of	NULL
protein	NULL
transport	NULL
between	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
(	NULL
Fritz	NULL
and	NULL
Green	NULL
,	NULL
1996	NULL
;	NULL
Arenzana-Seisdedos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
recently	NULL
demonstrated	NULL
that	NULL
upon	NULL
microinjection	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
Xenopus	NULL
oocyte	NULL
nuclei	NULL
or	NULL
overexpression	NULL
of	NULL
the	NULL
protein	NULL
by	NULL
transient	NULL
transfection	NULL
in	NULL
mammalian	NULL
Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
1582	NULL
cells	NULL
,	NULL
nuclear	NULL
IxBa	NULL
«	NULL
disrupts	NULL
NF-xB/DNA	NULL
binding	NULL
and	NULL
promotes	NULL
active	NULL
transport	NULL
of	NULL
NF-xB	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
(	NULL
Arenzana-Seisdedos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

All	NULL
these	NULL
findings	NULL
together	NULL
with	NULL
recent	NULL
in	NULL
vitro	NULL
experiments	NULL
(	NULL
Tran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
strongly	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
regulatory	NULL
role	NULL
by	NULL
retention	NULL
of	NULL
NF-xB	NULL
complexes	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
IxBa	NULL
«	NULL
could	NULL
act	NULL
as	NULL
a	NULL
'terminator	NULL
'	NULL
of	NULL
NF-xB	NULL
dependent	NULL
transcription	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Paradoxically	NULL
,	NULL
despite	NULL
the	NULL
key	NULL
role	NULL
played	NULL
by	NULL
NF-KB	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
immune-response	NULL
associated	NULL
genes	NULL
and	NULL
HIV	NULL
replication	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
regulation	NULL
of	NULL
NF-xB	NULL
and	NULL
IxBa	NULL
«	NULL
in	NULL
normal	NULL
,	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
(	NULL
Kang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Lai	NULL
and	NULL
Tan	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
question	NULL
remains	NULL
a	NULL
critical	NULL
matter	NULL
in	NULL
the	NULL
comprehension	NULL
of	NULL
IxBa	NULL
function	NULL
in	NULL
vivo	NULL
because	NULL
as	NULL
we	NULL
have	NULL
previously	NULL
demonstrated	NULL
for	NULL
HIV-LTR	NULL
transactivation	NULL
(	NULL
Alcami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
the	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
regulation	NULL
are	NULL
very	NULL
different	NULL
in	NULL
normal	NULL
cells	NULL
and	NULL
transformed	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
get	NULL
a	NULL
better	NULL
insight	NULL
into	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
nuclear	NULL
IxBa	NULL
in	NULL
a	NULL
physiological	NULL
context	NULL
we	NULL
analysed	NULL
the	NULL
expression	NULL
of	NULL
IxBa	NULL
and	NULL
IxB	NULL
&	NULL
«	NULL
/NF-xB	NULL
complexes	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
normal	NULL
T	NULL
lymphocytes	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
by	NULL
different	NULL
approaches	NULL
and	NULL
open	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
localization	NULL
could	NULL
be	NULL
relevant	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-xB	NULL
at	NULL
the	NULL
nuclear	NULL
level	NULL
.	NULL

Results	NULL
IxBx	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
Nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
from	NULL
purified	NULL
T	NULL
lymphocytes	NULL
were	NULL
analysed	NULL
for	NULL
IxBa	NULL
«	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
a	NULL
specific	NULL
monoclonal	NULL
antibody	NULL
against	NULL
IxBa	NULL
(	NULL
10B	NULL
)	NULL
(	NULL
Jaffray	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
la	NULL
,	NULL
IxBa	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
.	NULL

After	NULL
PMA	NULL
activation	NULL
,	NULL
a	NULL
transient	NULL
decrease	NULL
in	NULL
IxBa	NULL
«	NULL
levels	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
cytosol	NULL
at	NULL
30	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
return	NULL
to	NULL
basal	NULL
levels	NULL
12	NULL
h	NULL
after	NULL
cell	NULL
activation	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
IxBa	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
but	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
kinetics	NULL
observed	NULL
in	NULL
cytosol	NULL
in	NULL
which	NULL
IxB	NULL
«	NULL
decreases	NULL
quickly	NULL
after	NULL
cell	NULL
activation	NULL
,	NULL
a	NULL
progressive	NULL
increase	NULL
in	NULL
IxBa	NULL
«	NULL
levels	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
PMA-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
raise	NULL
in	NULL
nuclear	NULL
IxBa	NULL
«	NULL
levels	NULL
was	NULL
maximal	NULL
2	NULL
h	NULL
after	NULL
PMA	NULL
stimulation	NULL
and	NULL
was	NULL
maintained	NULL
up	NULL
to	NULL
6	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

After	NULL
this	NULL
time	NULL
nuclear	NULL
IxB	NULL
«	NULL
levels	NULL
decreased	NULL
and	NULL
a	NULL
return	NULL
to	NULL
basal	NULL
levels	NULL
was	NULL
seen	NULL
12	NULL
h	NULL
after	NULL
activation	NULL
.	NULL

Although	NULL
some	NULL
variability	NULL
on	NULL
IxBa	NULL
«	NULL
induction	NULL
was	NULL
observed	NULL
among	NULL
the	NULL
different	NULL
experiments	NULL
the	NULL
levels	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
PMA-activated	NULL
cells	NULL
were	NULL
consistently	NULL
higher	NULL
than	NULL
IxBa	NULL
levels	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

The	NULL
range	NULL
of	NULL
nuclear	NULL
IxBa	NULL
«	NULL
induction	NULL
2	NULL
h	NULL
after	NULL
PMA	NULL
activation	NULL
was	NULL
between	NULL
two-	NULL
and	NULL
tenfold	NULL
as	NULL
compared	NULL
to	NULL
non-activated	NULL
lymphocytes	NULL
.	NULL

IxBa	NULL
concentrations	NULL
in	NULL
nucleus	NULL
and	NULL
cytosol	NULL
were	NULL
assessed	NULL
by	NULL
densitometry	NULL
in	NULL
films	NULL
exposed	NULL
for	NULL
the	NULL
same	NULL
time	NULL
and	NULL
from	NULL
these	NULL
measurements	NULL
we	NULL
can	NULL
conclude	NULL
that	NULL
in	NULL
resting	NULL
lymphocytes	NULL
nuclear	NULL
IxB	NULL
«	NULL
concentration	NULL
is	NULL
about	NULL
5-10	NULL
%	NULL
of	NULL
cytoplasmic	NULL
concentrations	NULL
.	NULL

In	NULL
activated	NULL
cells	NULL
,	NULL
2	NULL
h	NULL
after	NULL
PMA	NULL
activation	NULL
similar	NULL
amounts	NULL
of	NULL
IxB	NULL
«	NULL
were	NULL
found	NULL
in	NULL
the	NULL
cytosol	NULL
and	NULL
the	NULL
nucleus	NULL
(	NULL
Figure	NULL
la	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
a	NULL
different	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
against	NULL
IxBa	NULL
(	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
nuclear	NULL
IxB	NULL
«	NULL
was	NULL
not	NULL
due	NULL
to	NULL
cytosolic	NULL
contamination	NULL
in	NULL
nuclear	NULL
cell	NULL
extracts	NULL
.	NULL

Several	NULL
methods	NULL
of	NULL
extraction	NULL
and	NULL
cell-fractionation	NULL
were	NULL
tested	NULL
in	NULL
preliminary	NULL
experiments	NULL
to	NULL
rule	NULL
out	NULL
cytosolic	NULL
contamination	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
systematically	NULL
checked	NULL
for	NULL
potential	NULL
contamination	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
two	NULL
different	NULL
proteins	NULL
of	NULL
exclusive	NULL
cytosolic	NULL
location	NULL
:	NULL
lactic	NULL
dehydrogenase	NULL
(	NULL
LDH	NULL
)	NULL
and	NULL
p105	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1¢c	NULL
,	NULL
both	NULL
proteins	NULL
were	NULL
undetectable	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
thus	NULL
excluding	NULL
cytosolic	NULL
contamination	NULL
of	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

Nuclear	NULL
IxB	NULL
«	NULL
is	NULL
detected	NULL
by	NULL
microscopy	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
To	NULL
confirm	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
IxBa	NULL
by	NULL
different	NULL
techniques	NULL
,	NULL
IxBa	NULL
«	NULL
localization	NULL
was	NULL
analysed	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
and	NULL
confocal	NULL
microscopy	NULL
techni-	NULL
a.	NULL
Cytoplasm	NULL
PMA	NULL
(	NULL
time	NULL
)	NULL
_	NULL
0	NULL
30°	NULL
120°	NULL
12h	NULL
b.	NULL
Nucleus	NULL
PMA	NULL
(	NULL
time	NULL
)	NULL
0	NULL
30°	NULL
120°	NULL
12	NULL
h	NULL
C.	NULL
Cytoplasm	NULL
Nucleus	NULL
p105	NULL
=	NULL
>	NULL
p50	NULL
=	NULL
>	NULL
PMA	NULL
{	NULL
time	NULL
)	NULL
O0	NULL
30°	NULL
120°	NULL
0	NULL
30°	NULL
120	NULL
Figure	NULL
1	NULL
IxB	NULL
«	NULL
is	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Purified	NULL
T	NULL
lymphocytes	NULL
were	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
25	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
IxBa	NULL
in	NULL
cytosolic	NULL
(	NULL
a	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
b	NULL
)	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
an	NULL
IxB	NULL
«	NULL
monoclonal	NULL
antibody	NULL
(	NULL
10B	NULL
)	NULL
.	NULL

Autoradiographs	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
were	NULL
exposed	NULL
for	NULL
the	NULL
same	NULL
time	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
Proteins	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
cytosolic	NULL
or	NULL
nuclear	NULL
extracts	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
two	NULL
proteins	NULL
with	NULL
exclusive	NULL
cytosolic	NULL
localization	NULL
:	NULL
p105	NULL
and	NULL
LDH	NULL
.	NULL

None	NULL
of	NULL
them	NULL
were	NULL
detectable	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
even	NULL
after	NULL
prolonged	NULL
gel	NULL
exposure	NULL
Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
1583	NULL
Figure	NULL
2	NULL
-	NULL
Localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
resting	NULL
or	NULL
PMA-stimulated	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
and	NULL
confocal	NULL
microscopy	NULL
techniques	NULL
.	NULL

Isolated	NULL
T	NULL
lymphocytes	NULL
were	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
25	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
4	NULL
h	NULL
before	NULL
being	NULL
processed	NULL
for	NULL
indirect	NULL
immunofluorescence	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
IxBa	NULL
(	NULL
10B	NULL
)	NULL
.	NULL

Slides	NULL
were	NULL
analysed	NULL
by	NULL
confocal	NULL
microscopy	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Cells	NULL
stained	NULL
with	NULL
control	NULL
antibodies	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Resting	NULL
T	NULL
lymphocytes	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
PMA-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Arrows	NULL
and	NULL
arrowheads	NULL
indicate	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
compartments	NULL
respectively	NULL
ques	NULL
using	NULL
an	NULL
IxB	NULL
«	NULL
antibody	NULL
(	NULL
10B	NULL
)	NULL
(	NULL
Jaffray	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
in	NULL
Figure	NULL
2	NULL
,	NULL
IxB	NULL
«	NULL
was	NULL
found	NULL
in	NULL
both	NULL
the	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
of	NULL
resting	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

After	NULL
PMA	NULL
activation	NULL
,	NULL
a	NULL
sharp	NULL
increase	NULL
in	NULL
IxBa	NULL
levels	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

Two	NULL
different	NULL
antibodies	NULL
against	NULL
IxBa	NULL
were	NULL
used	NULL
with	NULL
similar	NULL
results	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Confocal	NULL
microscopy	NULL
experiments	NULL
were	NULL
further	NULL
confirmed	NULL
by	NULL
immunogold	NULL
staining	NULL
and	NULL
electron	NULL
microscopy	NULL
analysis	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Labeling	NULL
with	NULL
a	NULL
specific	NULL
IxBa	NULL
monoclonal	NULL
antibody	NULL
(	NULL
10B	NULL
)	NULL
and	NULL
immunogold	NULL
particles	NULL
clearly	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
IxBa	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
PMA-activated	NULL
cells	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
nuclear	NULL
IxBa	NULL
«	NULL
in	NULL
activated	NULL
lymphocytes	NULL
did	NULL
not	NULL
appear	NULL
homogeneous	NULL
throughout	NULL
the	NULL
nucleoplasm	NULL
but	NULL
the	NULL
precise	NULL
nature	NULL
of	NULL
the	NULL
accumulation	NULL
of	NULL
IxBa	NULL
area	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

Kinetics	NULL
of	NULL
IxBx	NULL
degradation	NULL
and	NULL
synthesis	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
To	NULL
get	NULL
a	NULL
better	NULL
insight	NULL
into	NULL
the	NULL
kinetics	NULL
of	NULL
IxBa	NULL
«	NULL
synthesis	NULL
and	NULL
degradation	NULL
,	NULL
T	NULL
lymphocytes	NULL
were	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
1	NULL
h	NULL
before	NULL
activation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4a	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
,	NULL
cytosolic	NULL
IxB	NULL
«	NULL
was	NULL
undetectable	NULL
1h	NULL
after	NULL
PMA	NULL
activation	NULL
.	NULL

Therefore	NULL
,	NULL
rapid	NULL
degradation	NULL
and/or	NULL
translocation	NULL
of	NULL
cytosolic	NULL
IxBa	NULL
«	NULL
were	NULL
induced	NULL
by	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
CHX	NULL
treatment	NULL
,	NULL
IxBa	NULL
«	NULL
levels	NULL
were	NULL
continuously	NULL
detected	NULL
in	NULL
the	NULL
cytosol	NULL
thus	NULL
demonstrating	NULL
the	NULL
induction	NULL
of	NULL
de	NULL
novo	NULL
IxBa	NULL
«	NULL
synthesis	NULL
early	NULL
(	NULL
30	NULL
min	NULL
)	NULL
after	NULL
PMA	NULL
stimulation	NULL
as	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
systems	NULL
.	NULL

However	NULL
,	NULL
nuclear	NULL
IxBa	NULL
(	NULL
Figure	NULL
4b	NULL
)	NULL
was	NULL
still	NULL
detected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
and	NULL
persistence	NULL
of	NULL
the	NULL
protein	NULL
was	NULL
observed	NULL
later	NULL
after	NULL
IxBa	NULL
«	NULL
disappeared	NULL
from	NULL
the	NULL
cytosol	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
the	NULL
nuclear	NULL
pool	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
very	NULL
stable	NULL
and	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
,	NULL
independent	NULL
of	NULL
IxBa	NULL
resynthesis	NULL
.	NULL

Nuclear	NULL
IxBx	NULL
does	NULL
not	NULL
inhibit	NULL
NF-xB/DNA	NULL
interaction	NULL
To	NULL
define	NULL
the	NULL
potential	NULL
inhibitory	NULL
activity	NULL
of	NULL
nuclear	NULL
IxB	NULL
«	NULL
on	NULL
NF-xB	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
and	NULL
PMA	NULL
-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
were	NULL
analysed	NULL
in	NULL
Figure	NULL
3	NULL
Detection	NULL
of	NULL
IxBa	NULL
&	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
electron	NULL
microscopy	NULL
.	NULL

Resting	NULL
(	NULL
a	NULL
)	NULL
or	NULL
PMA-activated	NULL
lymphocytes	NULL
(	NULL
b	NULL
)	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
IxBa	NULL
(	NULL
10B	NULL
)	NULL
and	NULL
developed	NULL
with	NULL
an	NULL
anti-mouse	NULL
IgG	NULL
antibody	NULL
conjugated	NULL
with	NULL
gold	NULL
particles	NULL
a.	NULL
Cytoplasm	NULL
PMA	NULL
0	NULL
30°	NULL
60°	NULL
2h	NULL
0	NULL
30°	NULL
60°	NULL
zh	NULL
-	NULL
CHX	NULL
+	NULL
CHX	NULL
b.	NULL
Nucleus	NULL
PMA	NULL
0	NULL
30°	NULL
60°	NULL
2h	NULL
0	NULL
30°	NULL
60°	NULL
2h	NULL
-	NULL
CHX	NULL
+	NULL
CHX	NULL
Figure	NULL
4	NULL
Expression	NULL
of	NULL
IxBa	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
resynthesis	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
cytosolic	NULL
(	NULL
a	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
b	NULL
)	NULL
extracts	NULL
from	NULL
purified	NULL
human	NULL
T	NULL
lymphocytes	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
IxB	NULL
«	NULL
monoclonal	NULL
antibody	NULL
(	NULL
10B	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
activated	NULL
with	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
alone	NULL
(	NULL
-CHX	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
+CHX	NULL
)	NULL
.	NULL

When	NULL
used	NULL
,	NULL
CHX	NULL
was	NULL
added	NULL
60	NULL
min	NULL
before	NULL
PMA	NULL
activation	NULL
and	NULL
maintained	NULL
during	NULL
the	NULL
experiment	NULL
Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
1584	NULL
a.	NULL
C.	NULL
Supershifted	NULL
|	NULL
pes/pse	NULL
>	NULL
»	NULL
forms	NULL
>	NULL
pS0/cRel	NULL
»	NULL
p5O/ip50	NULL
3	NULL
»	NULL
PMA	NULL
(	NULL
time	NULL
)	NULL
0	NULL
_	NULL
30°	NULL
1200	NULL
12	NULL
%	NULL
gag	NULL
:	NULL
thougt	NULL
b.	NULL
p50/pS0	NULL
>	NULL
IkB-a	NULL
>	NULL
—	NULL
.	NULL
'	NULL

a	NULL
==	NULL
_	NULL
com	NULL
-	NULL
p5OAb	NULL
p€5Ab	NULL
cReAb	NULL
—eotha	NULL
PMA	NULL
(	NULL
time	NULL
)	NULL
.	NULL

0	NULL
_	NULL
30°	NULL
120°	NULL
-	NULL
12h	NULL
PMA-activated	NULL
PMA-activated	NULL
Figure	NULL
5	NULL
-	NULL
NF-xB/DNA	NULL
interaction	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
nuclear	NULL
IxBa	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Gel	NULL
retardation	NULL
assays	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
or	NULL
PMA-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
at	NULL
different	NULL
times	NULL
.	NULL

Bandshift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
dCTP-°P-labeled	NULL
oligonucleotide	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
xB	NULL
consensus	NULL
present	NULL
in	NULL
the	NULL
HIV-LTR	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

(	NULL
b	NULL
)	NULL
The	NULL
same	NULL
nuclear	NULL
extracts	NULL
shown	NULL
in	NULL
panel	NULL
a	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
a	NULL
specific	NULL
IxBa	NULL
«	NULL
antibody	NULL
(	NULL
10B	NULL
)	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
Competition	NULL
of	NULL
PMA-induced	NULL
Rel/NF-xB	NULL
complexes	NULL
.	NULL

Bandshift	NULL
assay	NULL
were	NULL
performed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
either	NULL
resting	NULL
or	NULL
PMA-activated	NULL
T	NULL
lymphocytes	NULL
and	NULL
competed	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
com	NULL
)	NULL
specific	NULL
antibodies	NULL
directed	NULL
against	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
c-Rel	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
recombinant	NULL
IxBa	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
different	NULL
NF-xB	NULL
binding	NULL
complexes	NULL
and	NULL
supershifted	NULL
forms	NULL
bandshift	NULL
assays	NULL
and	NULL
Western	NULL
blot	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
Sa	NULL
,	NULL
a	NULL
binding	NULL
complex	NULL
previously	NULL
a.	NULL
IP	NULL
pSO	NULL
characterized	NULL
by	NULL
our	NULL
group	NULL
and	NULL
others	NULL
(	NULL
Kang	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
.	NULL

,	NULL
ae	NULL
1992	NULL
;	NULL
Pimentel-Muifios	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Alcami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
65	NULL
as	NULL
p50	NULL
homodimers	NULL
was	NULL
detected	NULL
in	NULL
resting	NULL
T	NULL
P	NULL
»	NULL
i.-	NULL
.	NULL

lymphocytes	NULL
.	NULL

In	NULL
activated	NULL
cells	NULL
,	NULL
two	NULL
more	NULL
complexes	NULL
PMA	NULL
__-	NULL
__+	NULL
_	NULL
-	NULL
+	NULL
composed	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
were	NULL
N	NULL
C	NULL
induced	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Pimentel-Muifios	NULL
et	NULL
b	NULL
IP	NULL
p50	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Moore	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
(	NULL
Figure	NULL
5b	NULL
)	NULL
j	NULL
P	NULL
nuclear	NULL
IxBa	NULL
levels	NULL
increased	NULL
after	NULL
PMA	NULL
activation	NULL
and	NULL
this	NULL
increase	NULL
was	NULL
not	NULL
apparently	NULL
associated	NULL
with	NULL
an	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
binding	NULL
.	NULL

PMA	NULL
L	NULL
+	NULL
R	NULL
+	NULL
To	NULL
confirm	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
complexes	NULL
~*~	NULL
~	NULL
~a	NULL
induced	NULL
after	NULL
PMA	NULL
activation	NULL
,	NULL
competition	NULL
with	NULL
N	NULL
C	NULL
antibodies	NULL
directed	NULL
against	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
c-Rel	NULL
was	NULL
C.	NULL
IP	NULL
p65	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5c	NULL
at	NULL
least	NULL
two	NULL
complexes	NULL
composed	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/c-Rel	NULL
IkB-a	NULL
*	NULL
--	NULL
heterodimers	NULL
were	NULL
present	NULL
after	NULL
PMA	NULL
treatment	NULL
.	NULL

An	NULL
important	NULL
question	NULL
was	NULL
to	NULL
define	NULL
whether	NULL
or	NULL
not	NULL
NF-	NULL
PMA	NULL
_-	NULL
__+	NULL
__	NULL
:	NULL
*	NULL
xB	NULL
complexes	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
IxBa	NULL
«	NULL
or	NULL
were	NULL
N	NULL
C	NULL
protected	NULL
from	NULL
interaction	NULL
with	NULL
nuclear	NULL
IxB	NULL
«	NULL
.	NULL

In	NULL
competition	NULL
assays	NULL
(	NULL
Figure	NULL
5¢c	NULL
)	NULL
we	NULL
show	NULL
that	NULL
the	NULL
d.	NULL
IP	NULL
p50	NULL
binding	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/c-Rel	NULL
complexes	NULL
is	NULL
&	NULL
inhibited	NULL
in	NULL
vitro	NULL
by	NULL
recombinant	NULL
IxBa	NULL
.	NULL

c-Rel	NULL
>	NULL
l	NULL
tm	NULL
.	NULL

#	NULL
PMA	NULL
___-	NULL
___	NULL
#	NULL
_	NULL
_	NULL
_-	NULL
__	NULL
#	NULL
_	NULL
Nuclear	NULL
IxBa	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
p50	NULL
,	NULL
p65	NULL
or	NULL
c-Rel	NULL
N	NULL
C	NULL
proteins	NULL
e.	NULL
IP	NULL
IxB-	NULL
«	NULL
The	NULL
potential	NULL
interactions	NULL
of	NULL
IxB	NULL
«	NULL
with	NULL
rel/NF-xB	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
nuclei	NULL
were	NULL
analysed	NULL
by	NULL
c-Rel	NULL
>	NULL
A	NULL
hme	NULL
immunoprecipitation	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6a	NULL
,	NULL
after	NULL
immunoprecipitation	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
PMA	NULL
L	NULL
+	NULL
L	NULL
+	NULL
proteins	NULL
with	NULL
a	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
against	NULL
we-	NULL
_	NULL
z	NULL
z	NULL
___	NULL
p50	NULL
,	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-xB	NULL
was	NULL
detected	NULL
by	NULL
N	NULL
C	NULL
Western	NULL
blot	NULL
associated	NULL
with	NULL
p50	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
and	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
PMA-activated	NULL
lymphocytes	NULL
.	NULL

These	NULL
results	NULL
Figure	NULL
6	NULL
IxBa	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
p30	NULL
,	NULL
p65	NULL
or	NULL
c-Rel	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
resting	NULL
or	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

To	NULL
analyse	NULL
the	NULL
presence	NULL
of	NULL
NF-xB/IxB	NULL
«	NULL
complexes	NULL
400	NULL
ug	NULL
of	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
or	NULL
correlate	NULL
with	NULL
the	NULL
detection	NULL
by	NULL
Western	NULL
blot	NULL
of	NULL
p50	NULL
and	NULL
cytosolic	NULL
(	NULL
C	NULL
)	NULL
proteins	NULL
extracted	NULL
from	NULL
resting	NULL
(	NULL
-	NULL
)	NULL
or	NULL
PMA-p65	NULL
in	NULL
the	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
cellular	NULL
compartments	NULL
activated	NULL
(	NULL
+	NULL
)	NULL
T	NULL
lymphocytes	NULL
(	NULL
3	NULL
h	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
also	NULL
with	NULL
the	NULL
binding	NULL
results	NULL
antibodies	NULL
against	NULL
p50	NULL
(	NULL
a	NULL
,	NULL
b	NULL
and	NULL
d	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
c	NULL
)	NULL
and	NULL
IxBa	NULL
(	NULL
e	NULL
)	NULL
fgr	NULL
2	NULL
h.	NULL
described	NULL
in	NULL
Figure	NULL
5c	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
p50/c-Rel	NULL
A-Sepharose	NULL
beads	NULL
were	NULL
added	NULL
after	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
1	NULL
€	NULL
~	NULL
Iv	NULL
i	NULL
I	NULL
;	NULL
1	NULL
P	NULL
1	NULL
4°C	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

complexes	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
cytoso	NULL
Longer	NULL
exposure	NULL
of	NULL
the	NULL
membranes	NULL
did	NULL
not	NULL
yield	NULL
detection	NULL
of	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
(	NULL
Figure	NULL
6d	NULL
)	NULL
;	NULL
these	NULL
results	NULL
IxBa	NULL
in	NULL
nuclear	NULL
extracts	NULL
correlate	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
c-Rel	NULL
is	NULL
not	NULL
constitutively	NULL
expressed	NULL
in	NULL
unstimulated	NULL
PBLs	NULL
(	NULL
Pimentel-Muifios	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Moore	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
and	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

When	NULL
p50	NULL
or	NULL
p65-immunoprecipitated	NULL
complexes	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
a	NULL
specific	NULL
IxBa	NULL
«	NULL
monoclonal	NULL
antibody	NULL
(	NULL
10B	NULL
)	NULL
no	NULL
association	NULL
of	NULL
IxBa	NULL
with	NULL
p50	NULL
or	NULL
p65	NULL
proteins	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
(	NULL
Figure	NULL
6b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxBa	NULL
was	NULL
clearly	NULL
detected	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
associated	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
proteins	NULL
(	NULL
Figure	NULL
6b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6e	NULL
,	NULL
c-Rel	NULL
was	NULL
associated	NULL
with	NULL
IxBa	NULL
«	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
PMA-activated	NULL
cells	NULL
but	NULL
was	NULL
not	NULL
bound	NULL
to	NULL
IxB	NULL
«	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
either	NULL
resting	NULL
or	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

IxBB	NULL
is	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
As	NULL
it	NULL
has	NULL
been	NULL
described	NULL
that	NULL
could	NULL
associate	NULL
with	NULL
NF-xB	NULL
thus	NULL
preventing	NULL
its	NULL
association	NULL
with	NULL
IxBa	NULL
,	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
from	NULL
purified	NULL
T	NULL
lymphocytes	NULL
and	NULL
Jurkatt	NULL
cells	NULL
were	NULL
analysed	NULL
for	NULL
IxBB	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
a	NULL
specific	NULL
monoclonal	NULL
antibody	NULL
against	NULL
IxBB	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
,	NULL
IxBRB	NULL
was	NULL
only	NULL
barely	NULL
detectable	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
resting	NULL
human	NULL
T	NULL
lymphocytes	NULL
but	NULL
not	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
either	NULL
resting	NULL
or	NULL
PMA	NULL
-activated	NULL
T	NULL
cells	NULL
.	NULL

Discussion	NULL
According	NULL
to	NULL
current	NULL
models	NULL
,	NULL
IxB	NULL
«	NULL
would	NULL
remain	NULL
exclusively	NULL
in	NULL
the	NULL
cytoplasm	NULL
thus	NULL
preventing	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
.	NULL

However	NULL
,	NULL
IxB	NULL
«	NULL
has	NULL
also	NULL
been	NULL
described	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
under	NULL
different	NULL
experimental	NULL
conditions	NULL
in	NULL
which	NULL
the	NULL
protein	NULL
is	NULL
overexpressed	NULL
either	NULL
in	NULL
vitro	NULL
by	NULL
transient	NULL
transfection	NULL
(	NULL
Morin	NULL
and	NULL
Gilmore	NULL
,	NULL
1992	NULL
;	NULL
Cressman	NULL
and	NULL
Taub	NULL
,	NULL
1993	NULL
)	NULL
or	NULL
in	NULL
vivo	NULL
in	NULL
transgenic	NULL
p65	NULL
mice	NULL
(	NULL
Perez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
following	NULL
TNF	NULL
activation	NULL
IxBa	NULL
«	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
of	NULL
Hela	NULL
cells	NULL
(	NULL
Arenzana-Seisdedos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
associated	NULL
with	NULL
Rel/	NULL
NF-xB	NULL
complexes	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
addressed	NULL
this	NULL
question	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
because	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
NF-xB	NULL
is	NULL
an	NULL
essential	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
control	NULL
of	NULL
immune	NULL
response	NULL
and	NULL
HIV	NULL
replication	NULL
(	NULL
Alcami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Pimentel-Muifios	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
IxBa	NULL
shows	NULL
a	NULL
nuclear	NULL
localization	NULL
in	NULL
resting	NULL
and	NULL
PMA	NULL
Jurkatt	NULL
cells	NULL
PMA	NULL
_	NULL
-	NULL
+	NULL
=	NULL
+	NULL
=	NULL
+	NULL
=	NULL
+	NULL
Figure	NULL
7	NULL
IxB	NULL
#	NULL
is	NULL
not	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
cytosolic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
extracts	NULL
from	NULL
purified	NULL
T	NULL
lymphocytes	NULL
and	NULL
Jurkatt	NULL
cells	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
IxB	NULL
#	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
activated	NULL
(	NULL
+	NULL
)	NULL
or	NULL
not	NULL
(	NULL
-	NULL
)	NULL
with	NULL
PMA	NULL
Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
activated	NULL
peripheral	NULL
blood	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
three	NULL
different	NULL
techniques	NULL
:	NULL
Western	NULL
blot	NULL
,	NULL
confocal	NULL
microscopy	NULL
and	NULL
electron	NULL
microscopy	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
IxBa	NULL
synthesis	NULL
and	NULL
degradation	NULL
in	NULL
T	NULL
lymphocytes	NULL
was	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
in	NULL
CHX-treated	NULL
cells	NULL
.	NULL

PMA	NULL
activation	NULL
leads	NULL
to	NULL
a	NULL
rapid	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
cytosolic	NULL
extracts	NULL
together	NULL
with	NULL
a	NULL
resynthesis	NULL
of	NULL
the	NULL
protein	NULL
early	NULL
after	NULL
cell	NULL
activation	NULL
(	NULL
Figures	NULL
la	NULL
and	NULL
4a	NULL
)	NULL
.	NULL

This	NULL
kinetics	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
and	NULL
confirms	NULL
that	NULL
IxBa	NULL
degradation	NULL
is	NULL
also	NULL
a	NULL
major	NULL
mechanism	NULL
involved	NULL
in	NULL
activation-dependent	NULL
NF-xB	NULL
translocation	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
Lai	NULL
and	NULL
Tan	NULL
,	NULL
1994	NULL
;	NULL
Harhaj	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Although	NULL
some	NULL
variations	NULL
were	NULL
observed	NULL
among	NULL
different	NULL
experiments	NULL
,	NULL
the	NULL
lowest	NULL
level	NULL
of	NULL
cytosolic	NULL
IkBa	NULL
was	NULL
observed	NULL
2	NULL
h	NULL
after	NULL
PMA	NULL
treatment	NULL
followed	NULL
by	NULL
a	NULL
return	NULL
to	NULL
basal	NULL
levels	NULL
12	NULL
h	NULL
after	NULL
cell	NULL
activation	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
protein	NULL
resynthesis	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
barely	NULL
detectable	NULL
levels	NULL
of	NULL
IxBa	NULL
«	NULL
were	NULL
found	NULL
by	NULL
Western	NULL
blot	NULL
in	NULL
resting	NULL
cells	NULL
whereas	NULL
PMA	NULL
activation	NULL
quickly	NULL
induced	NULL
nuclear	NULL
expression	NULL
of	NULL
IxBa	NULL
«	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
(	NULL
between	NULL
two-and	NULL
ten-fold	NULL
depending	NULL
on	NULL
the	NULL
different	NULL
experiments	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IxB	NULL
«	NULL
levels	NULL
remain	NULL
stable	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
activated	NULL
T	NULL
lymphocytes	NULL
treated	NULL
with	NULL
PMA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
Figure	NULL
4b	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
IxBa	NULL
«	NULL
persists	NULL
in	NULL
the	NULL
nucleus	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
and	NULL
in	NULL
spite	NULL
of	NULL
continuous	NULL
cell	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
were	NULL
observed	NULL
using	NULL
both	NULL
a	NULL
monoclonal	NULL
antibody	NULL
and	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
IxBa	NULL
whose	NULL
specificity	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
(	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Jaffray	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
nuclear	NULL
IxB	NULL
«	NULL
was	NULL
further	NULL
verified	NULL
by	NULL
immunostaining	NULL
using	NULL
both	NULL
confocal	NULL
and	NULL
electron	NULL
microscopy	NULL
techniques	NULL
(	NULL
Figures	NULL
2	NULL
and	NULL
3	NULL
)	NULL
thus	NULL
confirming	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Western	NULL
blot	NULL
experiments	NULL
.	NULL

A	NULL
major	NULL
question	NULL
arising	NULL
from	NULL
the	NULL
detection	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
the	NULL
nucleus	NULL
was	NULL
to	NULL
define	NULL
whether	NULL
IxBa	NULL
expressed	NULL
in	NULL
this	NULL
compartment	NULL
was	NULL
in	NULL
an	NULL
'active	NULL
'	NULL
form	NULL
,	NULL
able	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
xB	NULL
binding	NULL
as	NULL
it	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
in	NULL
Hela	NULL
cells	NULL
(	NULL
Arenzana-Seisdedos	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
in	NULL
in	NULL
vitro	NULL
transcription	NULL
experiments	NULL
(	NULL
Tran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
binding	NULL
assays	NULL
were	NULL
done	NULL
at	NULL
different	NULL
times	NULL
after	NULL
PMA	NULL
activation	NULL
.	NULL

Unexpectedly	NULL
,	NULL
DNA	NULL
binding	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
was	NULL
not	NULL
affected	NULL
despite	NULL
of	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
nuclear	NULL
IxBa	NULL
«	NULL
detected	NULL
in	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
Figure	NULL
Sa	NULL
and	NULL
b	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
PMA	NULL
-activated	NULL
T	NULL
lymphocytes	NULL
recombinant	NULL
IxBa	NULL
was	NULL
able	NULL
to	NULL
disrupt	NULL
the	NULL
binding	NULL
of	NULL
either	NULL
p50/p65	NULL
or	NULL
p50/	NULL
c-Rel	NULL
complexes	NULL
to	NULL
DNA	NULL
(	NULL
Figure	NULL
5¢	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
latter	NULL
result	NULL
is	NULL
specially	NULL
relevant	NULL
as	NULL
it	NULL
shows	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
recombinant	NULL
IxB	NULL
«	NULL
,	NULL
'natural	NULL
IxB	NULL
«	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
,	NULL
unable	NULL
to	NULL
disrupt	NULL
NF-xB	NULL
binding	NULL
from	NULL
DNA	NULL
in	NULL
PMA-activated	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
were	NULL
further	NULL
confirmed	NULL
in	NULL
immunoprecipitation	NULL
experiments	NULL
in	NULL
which	NULL
no	NULL
association	NULL
between	NULL
IxBa	NULL
«	NULL
and	NULL
p50	NULL
,	NULL
p65	NULL
or	NULL
c-Rel	NULL
proteins	NULL
was	NULL
found	NULL
(	NULL
Figure	NULL
6b	NULL
,	NULL
c	NULL
and	NULL
e	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
experiments	NULL
correlated	NULL
with	NULL
the	NULL
kinetics	NULL
of	NULL
expression	NULL
of	NULL
Rel/NF-xB	NULL
proteins	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
p50	NULL
and	NULL
p65	NULL
NF-xB	NULL
subunits	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
resting	NULL
T-lymphocytes	NULL
but	NULL
in	NULL
contrast	NULL
c-Rel	NULL
is	NULL
induced	NULL
de	NULL
novo	NULL
by	NULL
lymphocyte	NULL
activation	NULL
(	NULL
Alcami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
1585	NULL
Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
1586	NULL
Pimentel-Muifios	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Moore	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
and	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

All	NULL
these	NULL
complexes	NULL
are	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
cell	NULL
activation	NULL
as	NULL
shown	NULL
in	NULL
bandshift	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
and	NULL
immunoprecipitation	NULL
experiments	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
newly	NULL
formed	NULL
p50/c-Rel	NULL
complexes	NULL
are	NULL
particularly	NULL
resistant	NULL
to	NULL
inactivation	NULL
by	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
«	NULL
(	NULL
Moore	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
compatible	NULL
with	NULL
this	NULL
hypothesis	NULL
because	NULL
in	NULL
the	NULL
cytosol	NULL
the	NULL
amount	NULL
of	NULL
IxBa	NULL
«	NULL
that	NULL
co-precipitates	NULL
with	NULL
p50	NULL
is	NULL
lower	NULL
in	NULL
activated	NULL
lymphocytes	NULL
as	NULL
compared	NULL
to	NULL
resting	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
p50/c-Rel	NULL
complexes	NULL
generated	NULL
after	NULL
cell	NULL
activation	NULL
are	NULL
easily	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
as	NULL
compared	NULL
to	NULL
p50/p65	NULL
dimers	NULL
that	NULL
would	NULL
be	NULL
more	NULL
sensitive	NULL
to	NULL
cytosolic	NULL
retention	NULL
by	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
«	NULL
.	NULL

However	NULL
,	NULL
in	NULL
nuclear	NULL
extracts	NULL
recombinant	NULL
IxB	NULL
«	NULL
is	NULL
able	NULL
to	NULL
disrupt	NULL
the	NULL
binding	NULL
of	NULL
either	NULL
p50/p65	NULL
or	NULL
p50/c-Rel	NULL
complexes	NULL
to	NULL
DNA	NULL
(	NULL
Figure	NULL
5c	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
thus	NULL
excluding	NULL
that	NULL
nuclear	NULL
p50/c-Rel	NULL
complexes	NULL
are	NULL
resistant	NULL
to	NULL
inactivation	NULL
by	NULL
IxBa	NULL
.	NULL

In	NULL
resting	NULL
lymphocytes	NULL
low	NULL
IxBa	NULL
levels	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
cytosol	NULL
compartment	NULL
.	NULL

From	NULL
densitometry	NULL
measurement	NULL
of	NULL
Western	NULL
blot	NULL
autoradiographs	NULL
exposed	NULL
for	NULL
the	NULL
same	NULL
time	NULL
we	NULL
could	NULL
estimate	NULL
that	NULL
IxB	NULL
«	NULL
concentration	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
resting	NULL
cells	NULL
was	NULL
about	NULL
5-10	NULL
%	NULL
of	NULL
the	NULL
levels	NULL
found	NULL
in	NULL
the	NULL
cytosolic	NULL
compartment	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
concentrations	NULL
of	NULL
IxBa	NULL
were	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytosol	NULL
2	NULL
h	NULL
after	NULL
PMA	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
nuclear	NULL
IxBa	NULL
is	NULL
easily	NULL
detected	NULL
thus	NULL
making	NULL
unlikely	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
binding	NULL
to	NULL
DNA	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
insufficient	NULL
amounts	NULL
of	NULL
IxB	NULL
«	NULL
.	NULL

Furthermore	NULL
,	NULL
using	NULL
confocal	NULL
microscopy	NULL
techniques	NULL
,	NULL
IxB	NULL
«	NULL
detection	NULL
was	NULL
particularly	NULL
intense	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
PMA-activated	NULL
lymphocytes	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
methods	NULL
used	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
proteins	NULL
could	NULL
result	NULL
in	NULL
leakage	NULL
of	NULL
unbound	NULL
IxBa	NULL
«	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytosol	NULL
thus	NULL
underestimating	NULL
the	NULL
levels	NULL
of	NULL
nuclear	NULL
IxBa	NULL
found	NULL
in	NULL
Western	NULL
blot	NULL
experiments	NULL
.	NULL

The	NULL
discrepancies	NULL
found	NULL
between	NULL
our	NULL
results	NULL
and	NULL
those	NULL
previously	NULL
described	NULL
in	NULL
activated	NULL
Hela	NULL
cells	NULL
in	NULL
which	NULL
NF-xB/IxBa	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
Arenzana-Seisdedos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
could	NULL
be	NULL
related	NULL
to	NULL
the	NULL
cell	NULL
type	NULL
and	NULL
the	NULL
different	NULL
stimuli	NULL
used	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
Hela	NULL
cells	NULL
active	NULL
IxB	NULL
«	NULL
was	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
only	NULL
when	NULL
transient	NULL
stimuli	NULL
as	NULL
ILl	NULL
or	NULL
a	NULL
TNF	NULL
pulse	NULL
were	NULL
used	NULL
whereas	NULL
persistent	NULL
cell	NULL
activation	NULL
leads	NULL
to	NULL
IxBa	NULL
«	NULL
degradation	NULL
and	NULL
permanent	NULL
NF-xB	NULL
translocation	NULL
.	NULL

In	NULL
our	NULL
system	NULL
,	NULL
T	NULL
lymphocytes	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
which	NULL
induces	NULL
a	NULL
strong	NULL
activation	NULL
leading	NULL
to	NULL
prolonged	NULL
translocation	NULL
of	NULL
NF-xB	NULL
(	NULL
Pimentel-Muifios	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
unbound	NULL
IxBa	NULL
«	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
PMA-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
may	NULL
be	NULL
due	NULL
to	NULL
different	NULL
reasons	NULL
:	NULL
IxBa	NULL
«	NULL
could	NULL
be	NULL
post-traductionally	NULL
modified	NULL
making	NULL
the	NULL
protein	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
NF-xB	NULL
and	NULL
resistant	NULL
to	NULL
degradation	NULL
as	NULL
it	NULL
has	NULL
been	NULL
described	NULL
for	NULL
cytosolic	NULL
IxBa	NULL
«	NULL
(	NULL
Imbert	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
recombinant	NULL
IxB	NULL
«	NULL
was	NULL
highly	NULL
efficient	NULL
to	NULL
inhibit	NULL
DNA	NULL
binding	NULL
of	NULL
Rel/NF-xB	NULL
proteins	NULL
in	NULL
bandshift	NULL
assays	NULL
(	NULL
Figure	NULL
5c	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Work	NULL
in	NULL
progress	NULL
in	NULL
our	NULL
laboratory	NULL
is	NULL
currently	NULL
analysing	NULL
the	NULL
post-traductional	NULL
modifications	NULL
of	NULL
the	NULL
nuclear	NULL
forms	NULL
of	NULL
IxBa	NULL
«	NULL
a	NULL
found	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Another	NULL
possibility	NULL
to	NULL
explain	NULL
the	NULL
incapacity	NULL
of	NULL
IxBa	NULL
«	NULL
to	NULL
retain	NULL
NF-KB	NULL
in	NULL
the	NULL
nucleus	NULL
could	NULL
be	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
proteins	NULL
interacting	NULL
either	NULL
with	NULL
NF-	NULL
«	NULL
xB	NULL
or	NULL
IxBa	NULL
«	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
has	NULL
been	NULL
described	NULL
that	NULL
IxB/	NULL
#	NULL
,	NULL
another	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
,	NULL
can	NULL
associate	NULL
with	NULL
NF-xB	NULL
thus	NULL
blocking	NULL
its	NULL
interaction	NULL
with	NULL
IxBa	NULL
(	NULL
Suyang	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
IxBB	NULL
has	NULL
been	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
associated	NULL
to	NULL
NF-xB	NULL
but	NULL
permitting	NULL
DNA	NULL
binding	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
(	NULL
Suyang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
did	NULL
not	NULL
show	NULL
any	NULL
detection	NULL
of	NULL
IxB	NULL
#	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
thus	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
IxBB	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB/IxBa	NULL
«	NULL
a	NULL
association	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
interaction	NULL
between	NULL
IxBa	NULL
«	NULL
and	NULL
a	NULL
yet	NULL
unidentified	NULL
protein	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

This	NULL
interaction	NULL
would	NULL
block	NULL
the	NULL
association	NULL
between	NULL
NF-xB	NULL
and	NULL
IxBa	NULL
«	NULL
and	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
would	NULL
stabilize	NULL
IxBa	NULL
«	NULL
thus	NULL
protecting	NULL
this	NULL
molecule	NULL
against	NULL
proteolysis	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

This	NULL
mechanism	NULL
would	NULL
be	NULL
overcome	NULL
if	NULL
large	NULL
quantities	NULL
of	NULL
IxBa	NULL
«	NULL
are	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
when	NULL
overexpressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
transfection	NULL
up	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
transiently	NULL
expressed	NULL
IxBa	NULL
localizes	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
a	NULL
close	NULL
correlation	NULL
between	NULL
nuclear	NULL
IxB	NULL
«	NULL
levels	NULL
and	NULL
inhibition	NULL
of	NULL
LTR	NULL
transactivation	NULL
and	NULL
HIV	NULL
replication	NULL
is	NULL
observed	NULL
(	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

These	NULL
preliminary	NULL
results	NULL
argue	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
IxB	NULL
«	NULL
could	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
as	NULL
previously	NULL
suggested	NULL
(	NULL
Morin	NULL
and	NULL
Gilmore	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
IxBa	NULL
localizes	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
lymphocytic	NULL
activation	NULL
and	NULL
in	NULL
contrast	NULL
with	NULL
its	NULL
role	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
it	NULL
is	NULL
apparently	NULL
devoid	NULL
of	NULL
any	NULL
inhibitory	NULL
function	NULL
.	NULL

Further	NULL
work	NULL
is	NULL
needed	NULL
to	NULL
understand	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
nuclear	NULL
IxBa	NULL
«	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
culture	NULL
Jurkatt	NULL
is	NULL
a	NULL
CD4*	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

Human	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
whole	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
centrifugation	NULL
in	NULL
Ficoll-Hypaque	NULL
(	NULL
Whitaker	NULL
)	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
purified	NULL
by	NULL
passing	NULL
through	NULL
a	NULL
nylon	NULL
fiber	NULL
wool	NULL
column	NULL
(	NULL
Robbins	NULL
Scientific	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
enriched	NULL
T	NULL
cell	NULL
population	NULL
was	NULL
always	NULL
above	NULL
95	NULL
%	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Whitaker	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Whitaker	NULL
)	NULL
,	NULL
glutamine	NULL
and	NULL
antibiotics	NULL
(	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
cytoplasmatic	NULL
and	NULL
nuclear	NULL
extracts	NULL
Purified	NULL
T	NULL
lymphocytes	NULL
were	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
25	NULL
ng/ml	NULL
of	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
at	NULL
37°C	NULL
in	NULL
culture	NULL
medium	NULL
at	NULL
different	NULL
times	NULL
.	NULL

When	NULL
cycloheximide	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

(	NULL
Sigma	NULL
)	NULL
was	NULL
incorporated	NULL
into	NULL
the	NULL
cultures	NULL
,	NULL
it	NULL
was	NULL
added	NULL
1	NULL
h	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
PMA	NULL
activation	NULL
and	NULL
was	NULL
maintained	NULL
throughout	NULL
the	NULL
culture	NULL
period	NULL
.	NULL

After	NULL
culture	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
A	NULL
)	NULL
during	NULL
5	NULL
min	NULL
as	NULL
described	NULL
(	NULL
Bachelerie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
the	NULL
supernatant	NULL
to	NULL
prepare	NULL
cytosolic	NULL
extracts	NULL
,	NULL
the	NULL
nuclear	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
washing	NULL
buffer	NULL
(	NULL
B	NULL
)	NULL
(	NULL
same	NULL
composition	NULL
as	NULL
lysis	NULL
buffer	NULL
without	NULL
Triton	NULL
X-100	NULL
)	NULL
centrifuged	NULL
at	NULL
4000	NULL
g	NULL
for	NULL
3	NULL
min	NULL
and	NULL
washed	NULL
.	NULL

After	NULL
careful	NULL
removal	NULL
of	NULL
the	NULL
supernatant	NULL
nucleic	NULL
pellets	NULL
were	NULL
resuspended	NULL
and	NULL
maintained	NULL
in	NULL
permanent	NULL
agitation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
100	NULL
wl	NULL
of	NULL
elution	NULL
buffer	NULL
(	NULL
C	NULL
)	NULL
(	NULL
Bachelerie	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Nuclear	NULL
fractions	NULL
were	NULL
recovered	NULL
after	NULL
centrifugation	NULL
at	NULL
4000	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cytosolic	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
the	NULL
same	NULL
procedure	NULL
as	NULL
nuclear	NULL
extracts	NULL
after	NULL
lyse	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
buffer	NULL
A	NULL
.	NULL

The	NULL
resultant	NULL
supernatant	NULL
containing	NULL
cytosolic	NULL
proteins	NULL
was	NULL
treated	NULL
by	NULL
adding	NULL
15	NULL
%	NULL
glycerol	NULL
and	NULL
1	NULL
%	NULL
NP-40	NULL
.	NULL

Gel	NULL
retardation	NULL
assay	NULL
Three	NULL
ug	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
were	NULL
analysed	NULL
as	NULL
described	NULL
(	NULL
Arenzana-Seisdedos	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
using	NULL
a	NULL
«	NULL
P-dCTP	NULL
labeled	NULL
double-stranded	NULL
synthetic	NULL
wild	NULL
type	NULL
HIV	NULL
enhancer	NULL
oligonucleotide	NULL
S'-AGCTTACAAGGGACTTT-CCGCTGGGGACTTTCCAGGGA-3	NULL
'	NULL
.	NULL

Binding	NULL
competition	NULL
was	NULL
assessed	NULL
by	NULL
pre-incubating	NULL
the	NULL
extract	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
and	NULL
specific	NULL
antibodies	NULL
:	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
or	NULL
recombinant	NULL
IxB	NULL
«	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
RT	NULL
Hay	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
Ten	NULL
ug	NULL
of	NULL
nuclear	NULL
or	NULL
cytosolic	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
PVDF	NULL
,	NULL
Sigma	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Probing	NULL
of	NULL
the	NULL
membranes	NULL
was	NULL
done	NULL
with	NULL
the	NULL
following	NULL
antibodies	NULL
:	NULL
monoclonal	NULL
IxB	NULL
«	NULL
(	NULL
10B	NULL
)	NULL
which	NULL
recognizes	NULL
an	NULL
epitope	NULL
located	NULL
between	NULL
amino	NULL
acids	NULL
24	NULL
and	NULL
48	NULL
of	NULL
IxBa	NULL
(	NULL
Jaffray	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
IxBa	NULL
«	NULL
(	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
p50/p105	NULL
(	NULL
all	NULL
kindly	NULL
provided	NULL
by	NULL
RT	NULL
Hay	NULL
)	NULL
polyclonal	NULL
«	NULL
-LDH	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
R	NULL
Bravo	NULL
)	NULL
and	NULL
polyclonal	NULL
c-Rel	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
N	NULL
Rice	NULL
)	NULL
.	NULL

The	NULL
following	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
:	NULL
rabbit	NULL
polyclonal	NULL
p50	NULL
(	NULL
NLS	NULL
,	NULL
se-114	NULL
)	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
p65	NULL
(	NULL
C-20	NULL
,	NULL
sc-372	NULL
)	NULL
and	NULL
rabbit	NULL
polyclonal	NULL
IxBR	NULL
(	NULL
G-20	NULL
,	NULL
se-944	NULL
)	NULL
.	NULL

Antigen-antibody	NULL
interactions	NULL
were	NULL
revealed	NULL
using	NULL
a	NULL
chemiluminescence	NULL
detection	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
performed	NULL
the	NULL
membranes	NULL
were	NULL
exposed	NULL
from	NULL
5	NULL
min	NULL
to	NULL
1	NULL
h	NULL
to	NULL
ensure	NULL
full	NULL
detection	NULL
of	NULL
the	NULL
proteins	NULL
.	NULL

The	NULL
exposure	NULL
time	NULL
that	NULL
is	NULL
shown	NULL
for	NULL
Western	NULL
blot	NULL
figures	NULL
of	NULL
IkB	NULL
«	NULL
,	NULL
IkBB	NULL
and	NULL
LDH	NULL
is	NULL
1h	NULL
.	NULL

Autoradiographs	NULL
were	NULL
scanned	NULL
and	NULL
analysed	NULL
using	NULL
the	NULL
'Diversity	NULL
one	NULL
'	NULL
software	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
Four	NULL
hundred	NULL
ug	NULL
of	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
different	NULL
antibodies	NULL
and	NULL
maintained	NULL
with	NULL
agitation	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Thirty	NULL
ul	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Calbiochem	NULL
,	NULL
USA	NULL
)	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
beads	NULL
were	NULL
washed	NULL
six	NULL
times	NULL
with	NULL
RIPA	NULL
buffer	NULL
.	NULL

Immunoprecipi-	NULL
References	NULL
Alcami	NULL
J	NULL
,	NULL
Lain	NULL
de	NULL
Lera	NULL
T	NULL
,	NULL
Folgueira	NULL
L	NULL
,	NULL
Pedraza	NULL
MA	NULL
,	NULL
Jacqué	NULL
JM	NULL
,	NULL
Bachelerie	NULL
F	NULL
,	NULL
Noriega	NULL
A	NULL
,	NULL
Hay	NULL
R	NULL
,	NULL
Harrich	NULL
D	NULL
,	NULL
Gaynor	NULL
R	NULL
,	NULL
Virelizier	NULL
JL	NULL
and	NULL
Arenzana	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
1552-1560	NULL
.	NULL

Arenzana-Seisdedos	NULL
F	NULL
,	NULL
Thompson	NULL
J	NULL
,	NULL
Rodriguez	NULL
MS	NULL
,	NULL
Bachelerie	NULL
F	NULL
,	NULL
Thomas	NULL
D	NULL
and	NULL
Hay	NULL
RT	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
2689-2696	NULL
.	NULL

Arenzana-Seisdedos	NULL
F	NULL
,	NULL
Turpin	NULL
P	NULL
,	NULL
Rodriguez	NULL
M	NULL
,	NULL
Thomas	NULL
D	NULL
,	NULL
Hay	NULL
RT	NULL
,	NULL
Virelizier	NULL
JL	NULL
and	NULL
Dargemont	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

,	NULL
110	NULL
,	NULL
369-378	NULL
.	NULL

Bachelerie	NULL
F	NULL
,	NULL
Alcami	NULL
J	NULL
,	NULL
Arenzana-Seisdedos	NULL
F	NULL
and	NULL
Virelizier	NULL
J-L.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
350	NULL
,	NULL
709-712	NULL
.	NULL

Bacuerle	NULL
PA	NULL
and	NULL
Henkel	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
141-179	NULL
.	NULL

Bacuerle	NULL
PA	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
87	NULL
,	NULL
13-20	NULL
.	NULL

Baldwin	NULL
Jr	NULL
AS	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
649-683	NULL
.	NULL

Beg	NULL
A	NULL
,	NULL
Finco	NULL
T	NULL
,	NULL
Nantermet	NULL
P	NULL
and	NULL
Baldwin	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Mo/	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
3301-3310	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
tated	NULL
proteins	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

Confocal	NULL
microscopy	NULL
Isolated	NULL
T	NULL
lymphocytes	NULL
were	NULL
attached	NULL
to	NULL
poly-L-lysine	NULL
coated	NULL
coverslips	NULL
,	NULL
fixed	NULL
for	NULL
10	NULL
min	NULL
in	NULL
2	NULL
%	NULL
paraformalde-hyde	NULL
,	NULL
0.1	NULL
%	NULL
glutaraldehyde	NULL
and	NULL
permeabilized	NULL
with	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
against	NULL
IxB	NULL
«	NULL
(	NULL
10B	NULL
)	NULL
was	NULL
applied	NULL
for	NULL
30	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
30	NULL
min	NULL
incubation	NULL
with	NULL
FITC-conjugated	NULL
donkey	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Jackson	NULL
Laboratory	NULL
)	NULL
.	NULL

Coverslips	NULL
were	NULL
mounted	NULL
in	NULL
Moviol	NULL
(	NULL
Hoechst	NULL
)	NULL
.	NULL

Confocal	NULL
laser	NULL
scanning	NULL
microscopy	NULL
and	NULL
immunofluorescence	NULL
analysis	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
TCS4D	NULL
confocal	NULL
microscope	NULL
based	NULL
on	NULL
a	NULL
DM	NULL
microscope	NULL
interfaced	NULL
with	NULL
a	NULL
mixed	NULL
gas	NULL
argon-krypton	NULL
laser	NULL
(	NULL
Leica	NULL
Laser	NULL
Technik	NULL
)	NULL
.	NULL

Fluorescence	NULL
acquisitions	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
488	NULL
nm	NULL
laser	NULL
lines	NULL
to	NULL
excite	NULL
FITC	NULL
dye	NULL
with	NULL
a	NULL
x	NULL
100	NULL
oil	NULL
immersion	NULL
PL	NULL
APO	NULL
objective	NULL
.	NULL

Cells	NULL
stained	NULL
with	NULL
control	NULL
antibodies	NULL
(	NULL
mouse	NULL
IgG	NULL
,	NULL
Coulter	NULL
)	NULL
and	NULL
an	NULL
FITC-conjugated	NULL
donkey	NULL
anti-mouse	NULL
IgG	NULL
did	NULL
not	NULL
give	NULL
detectable	NULL
signal	NULL
in	NULL
the	NULL
conditions	NULL
described	NULL
.	NULL

Electron	NULL
microscopy	NULL
T	NULL
cells	NULL
,	NULL
stimulated	NULL
as	NULL
indicated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2	NULL
x	NULL
were	NULL
fixed	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
paraformaldehyde	NULL
4	NULL
%	NULL
and	NULL
glutaraldehyde	NULL
0.025	NULL
%	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Pellets	NULL
were	NULL
then	NULL
dried	NULL
and	NULL
included	NULL
in	NULL
Lowicryl	NULL
K4M	NULL
for	NULL
cutting	NULL
.	NULL

Cuts	NULL
were	NULL
immunostained	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
IxBa	NULL
«	NULL
using	NULL
as	NULL
secondary	NULL
antibody	NULL
a	NULL
rabbit	NULL
anti-mouse	NULL
IgG	NULL
conjugated	NULL
with	NULL
gold	NULL
particles	NULL
15	NULL
nm	NULL
diameter	NULL
(	NULL
BioCell	NULL
)	NULL
.	NULL

Uranile	NULL
acetate	NULL
and	NULL
lead	NULL
citrate	NULL
was	NULL
used	NULL
for	NULL
electron	NULL
density	NULL
staining	NULL
.	NULL

Acknowledgments	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
Fondo	NULL
de	NULL
Investigaciones	NULL
Sanitarias	NULL
(	NULL
94/200	NULL
and	NULL
94/1904E	NULL
)	NULL
,	NULL
Minis-terio	NULL
de	NULL
Educacion	NULL
y	NULL
Ciencia	NULL
(	NULL
SAF	NULL
96/0186	NULL
)	NULL
,	NULL
Fundacion	NULL
Caja	NULL
de	NULL
Madrid	NULL
and	NULL
Fundacion	NULL
Ramon	NULL
Areces	NULL
,	NULL
Comuni-dad	NULL
de	NULL
Madrid	NULL
,	NULL
ATIRE-CNRS	NULL
,	NULL
Association	NULL
de	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
and	NULL
European	NULL
Community	NULL
Concerted	NULL
Action	NULL
(	NULL
Project	NULL
ROCIO	NULL
)	NULL
.	NULL

TLL	NULL
was	NULL
supported	NULL
by	NULL
Minis-terio	NULL
de	NULL
Educacion	NULL
.	NULL

MAP	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
Chiron	NULL
Corporation	NULL
and	NULL
MB	NULL
by	NULL
Abbott	NULL
Laboratories	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Dr	NULL
R	NULL
Bravo	NULL
,	NULL
Dr	NULL
Ron	NULL
T	NULL
Hay	NULL
and	NULL
Dr	NULL
N	NULL
Rice	NULL
for	NULL
the	NULL
antibodies	NULL
provided	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
the	NULL
Hematology	NULL
Department	NULL
for	NULL
its	NULL
collaboration	NULL
.	NULL

Beg	NULL
A	NULL
and	NULL
Baldwin	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
2064-2070	NULL
.	NULL

Bours	NULL
V	NULL
,	NULL
Villalobos	NULL
J	NULL
,	NULL
Burd	NULL
PR	NULL
,	NULL
Kelly	NULL
K	NULL
and	NULL
Siebenlist	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
348	NULL
,	NULL
76-80	NULL
.	NULL

Cressman	NULL
DE	NULL
and	NULL
Taub	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
8	NULL
,	NULL
2567-2573	NULL
.	NULL

Chen	NULL
BK	NULL
,	NULL
Feinberg	NULL
MK	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Viro/	NULL
.	NULL

,	NULL
71	NULL
,	NULL
5495-5504	NULL
.	NULL

Dobrzanski	NULL
P	NULL
,	NULL
Ryseck	NULL
R	NULL
and	NULL
Bravo	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
1572-1582	NULL
.	NULL

Finco	NULL
T	NULL
and	NULL
Baldwin	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
3	NULL
,	NULL
263-272	NULL
.	NULL

Fritz	NULL
CC	NULL
and	NULL
Green	NULL
MR.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
,	NULL
848-854	NULL
.	NULL

Fujita	NULL
T	NULL
,	NULL
Nolan	NULL
GP	NULL
,	NULL
Ghosh	NULL
S	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
775-787	NULL
.	NULL

Ghosh	NULL
S	NULL
,	NULL
Tan	NULL
T-H	NULL
,	NULL
Rice	NULL
N	NULL
,	NULL
Sica	NULL
A	NULL
and	NULL
Young	NULL
HA	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
1696-1700	NULL
.	NULL

Ghosh	NULL
S	NULL
,	NULL
Michael	NULL
JM	NULL
and	NULL
Kopp	NULL
EB	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
225-260	NULL
.	NULL

Harhaj	NULL
EW	NULL
,	NULL
Maggirwar	NULL
SB	NULL
and	NULL
Good	NULL
Land	NULL
Sun	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
6736-6742	NULL
.	NULL

1587	NULL
Nuclear	NULL
localization	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
T-lymphocytes	NULL
T	NULL
Lain	NULL
de	NULL
Lera	NULL
et	NULL
al	NULL
1588	NULL
Haskill	NULL
S	NULL
,	NULL
Beg	NULL
AA	NULL
,	NULL
Tompkin	NULL
SM	NULL
,	NULL
Morris	NULL
JS	NULL
,	NULL
Yurochko	NULL
AD	NULL
,	NULL
Sampson-Johannes	NULL
A	NULL
,	NULL
Mondal	NULL
K	NULL
,	NULL
Ralph	NULL
P	NULL
and	NULL
Baldwin	NULL
AS	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
,	NULL
1281-1289	NULL
.	NULL

Henkel	NULL
T	NULL
,	NULL
Zabel	NULL
U	NULL
,	NULL
Zee	NULL
KV	NULL
,	NULL
Miiller	NULL
JM	NULL
,	NULL
Fanning	NULL
E	NULL
and	NULL
Bacuerle	NULL
PA.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
68	NULL
,	NULL
1121-1133	NULL
.	NULL

Imbert	NULL
V	NULL
,	NULL
Rupec	NULL
RA	NULL
,	NULL
Livolsi	NULL
A	NULL
,	NULL
Pahl	NULL
HL	NULL
,	NULL
Britta-Mareen	NULL
Traenckner	NULL
E	NULL
,	NULL
Mueller-Dieckmann	NULL
C	NULL
,	NULL
Farahifar	NULL
D	NULL
,	NULL
Rossi	NULL
B	NULL
,	NULL
Auberger	NULL
P	NULL
,	NULL
Baeuerle	NULL
PA	NULL
and	NULL
Peyron	NULL
J-F.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
86	NULL
,	NULL
787-798	NULL
.	NULL

Jaffray	NULL
E	NULL
,	NULL
Wood	NULL
KM	NULL
and	NULL
Hay	NULL
RT	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
2166-2172	NULL
.	NULL

Kang	NULL
S	NULL
,	NULL
Tran	NULL
A	NULL
,	NULL
Grilli	NULL
M	NULL
and	NULL
Lenardo	NULL
MJ	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
256	NULL
,	NULL
1452-1456	NULL
.	NULL

Kieran	NULL
M	NULL
,	NULL
Blank	NULL
V	NULL
,	NULL
Logeat	NULL
F	NULL
,	NULL
Vandekerckhove	NULL
J	NULL
,	NULL
Lottspeic	NULL
F	NULL
,	NULL
Le	NULL
Bail	NULL
O	NULL
,	NULL
Urban	NULL
MB	NULL
,	NULL
Kourilsky	NULL
P	NULL
,	NULL
Baeuerle	NULL
PA	NULL
and	NULL
Israél	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Kretzschmar	NULL
M	NULL
,	NULL
Meisterernst	NULL
M	NULL
,	NULL
Scheidereit	NULL
C	NULL
,	NULL
Li	NULL
G	NULL
and	NULL
Roeder	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
761-774	NULL
.	NULL

Lai	NULL
J-H	NULL
and	NULL
Tan	NULL
T-H.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
259	NULL
,	NULL
30077	NULL
30080	NULL
.	NULL

Lin	NULL
L	NULL
,	NULL
De	NULL
Martino	NULL
GN	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
92	NULL
,	NULL
819-823	NULL
.	NULL

Lin	NULL
YC	NULL
,	NULL
Brown	NULL
K	NULL
and	NULL
Siebenlist	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Nat/	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
552-556	NULL
.	NULL

Matthews	NULL
JR	NULL
,	NULL
Watson	NULL
EA	NULL
,	NULL
Buckley	NULL
SL	NULL
and	NULL
Hay	NULL
RT	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
21	NULL
,	NULL
4516-4523	NULL
.	NULL

Moore	NULL
NC	NULL
,	NULL
Girdlestone	NULL
J	NULL
,	NULL
Anderson	NULL
G	NULL
,	NULL
Owen	NULL
JJT	NULL
and	NULL
Jenkison	NULL
EJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
,	NULL
4653-4660	NULL
.	NULL

Morin	NULL
PJ	NULL
and	NULL
Gilmore	NULL
TD	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
20	NULL
,	NULL
2453-2458	NULL
.	NULL

Nakayama	NULL
K	NULL
,	NULL
Shimizu	NULL
H	NULL
,	NULL
Mitomo	NULL
K	NULL
,	NULL
Watanebe	NULL
T	NULL
,	NULL
Okamoto	NULL
S	NULL
and	NULL
Yamamoto	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
1736-1746	NULL
.	NULL

Neri	NULL
A	NULL
,	NULL
Chang	NULL
C	NULL
,	NULL
Lombardi	NULL
L	NULL
,	NULL
Salina	NULL
M	NULL
,	NULL
Corradini	NULL
P	NULL
,	NULL
Maiolo	NULL
AT	NULL
,	NULL
Chaganti	NULL
RSK	NULL
and	NULL
Dalla-Favera	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
67	NULL
,	NULL
1075-1087	NULL
.	NULL

Nolan	NULL
GP	NULL
,	NULL
Ghosh	NULL
S	NULL
,	NULL
Liou	NULL
HC	NULL
,	NULL
Tempst	NULL
P	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Ohno	NULL
H	NULL
,	NULL
Takimoto	NULL
G	NULL
and	NULL
McKeithan	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
60	NULL
,	NULL
991-997	NULL
.	NULL

Perez	NULL
P	NULL
,	NULL
Lira	NULL
SA	NULL
and	NULL
Bravo	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
3523-3530	NULL
.	NULL

Perkins	NULL
ND	NULL
,	NULL
Schmid	NULL
RM	NULL
,	NULL
Duckett	NULL
CS	NULL
,	NULL
Leung	NULL
K	NULL
,	NULL
Rice	NULL
NR	NULL
and	NULL
Nabel	NULL
GJ	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
1529-1533	NULL
.	NULL

Pimentel-Muifios	NULL
FX	NULL
,	NULL
Mazana	NULL
J	NULL
and	NULL
Fresno	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
24424-24429	NULL
.	NULL

Pimentel-Muifios	NULL
FX	NULL
,	NULL
Mazana	NULL
J	NULL
and	NULL
Fresno	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
25	NULL
,	NULL
179-186	NULL
.	NULL

Rice	NULL
NR	NULL
,	NULL
Mackichan	NULL
ML	NULL
and	NULL
Israél	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
71	NULL
,	NULL
243-253	NULL
.	NULL

Roff	NULL
M	NULL
,	NULL
Thompson	NULL
J	NULL
,	NULL
Rodriguez	NULL
M	NULL
,	NULL
Jacqué	NULL
JM	NULL
,	NULL
Baleux	NULL
F	NULL
,	NULL
Arenzana	NULL
F	NULL
and	NULL
Hay	NULL
RT	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
7844-7850	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Dillon	NULL
PJ	NULL
,	NULL
Schreck	NULL
R	NULL
,	NULL
Henkel	NULL
T	NULL
,	NULL
Chen	NULL
CH	NULL
,	NULL
Maher	NULL
M	NULL
,	NULL
Baecuerle	NULL
PA	NULL
and	NULL
Rosen	NULL
CA	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Suyang	NULL
H	NULL
,	NULL
Phillips	NULL
R	NULL
,	NULL
Douglas	NULL
I	NULL
and	NULL
Ghosh	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Mo	NULL
!	NULL

/	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
5444-5449	NULL
.	NULL

Thompson	NULL
JE	NULL
,	NULL
Phillips	NULL
RJ	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Tempst	NULL
P	NULL
and	NULL
Ghosh	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
,	NULL
573-582	NULL
.	NULL

Tran	NULL
K	NULL
,	NULL
Merika	NULL
M	NULL
and	NULL
Thanos	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
5386-5399	NULL
.	NULL

Traenckner	NULL
EBM	NULL
,	NULL
Wilk	NULL
S	NULL
and	NULL
Baeuerle	NULL
PA.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
5433-5441	NULL
.	NULL

Verma	NULL
IM	NULL
,	NULL
Stevenson	NULL
JK	NULL
,	NULL
Schwarz	NULL
EM	NULL
,	NULL
VanAntwerp	NULL
D	NULL
and	NULL
Miyamoto	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
2723-2735	NULL
.	NULL

Whiteside	NULL
S	NULL
,	NULL
Epinat	NULL
JC	NULL
,	NULL
Rice	NULL
N	NULL
and	NULL
Israél	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
1413-1426	NULL
.	NULL

